• No results found

University of Groningen Complement activation in chronic kidney disease and dialysis Gaya da Costa, Mariana

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Complement activation in chronic kidney disease and dialysis Gaya da Costa, Mariana"

Copied!
7
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Complement activation in chronic kidney disease and dialysis

Gaya da Costa, Mariana

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2019

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Gaya da Costa, M. (2019). Complement activation in chronic kidney disease and dialysis. Rijksuniversiteit

Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Complement activation in

chronic kidney disease and dialysis

(3)

Cover: Denis Milani Adriano

Design and layout: Legatron Electronic Publishing, Rotterdam Printing: Ipskamp Printing, Enschede

June 2019

Copyright 2019 © Mariana Gaya Da Costa

ISBN: 978-94-034-1692-2 Printed book

ISBN: 978-94-034-1691-5 Digital version

Financial support for printing this thesis was kindly provided by: University of Groningen

University Medical Center Groningen Groningen Institute for Drug Exploration Hycult Biotechnology

ERBE Nederland BV Chipsoft

Financial support by the Dutch Heart Foundation for the publication of this thesis is gratefully acknowledged.

Financial support by the Dutch Kidney Foundation for the publication of this thesis is gratefully acknowledged.

No part of this thesis may be reproduced, stored in a retrieval system or transmitted in any form or by any means without permission from the author or, when appropriate, from the publishers of the publications.

(4)

Complement activation in

chronic kidney disease and dialysis

Proefschrift

ter verkrijging van de graad van doctor aan de

Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. E. Sterken

en volgens besluit van het College voor Promoties.

De openbare verdediging zal plaatsvinden op

maandag 17 juni 2019 om 16.15 uur

door

Mariana Gaya Da Costa

geboren op 5 januari 1989

te São Paulo, Brazilië

(5)

Promotores

Prof. dr. W.J. van Son Prof. dr. J.O. Medina Pestana

Copromotores

Dr. M.A.J. Seelen Dr. F. Poppelaars

Beoordelingscommissie

Prof. dr. B. Yard Prof. dr. H.G.D. Leuvenink Prof. dr. J.L. Hillebrands

(6)

Table of contents

Chapter 1 General Introduction 7

Chapter 2 The Lectin Pathway in Renal Disease: Old Concept and New Insights 13 Nephrology Dialysis Transplantation, 2018

Chapter 3 The Complement System in Dialysis: A Forgotten Story? 27 Frontiers in Immunology, 2018

Chapter 4 The Strong Predictive Value of Mannose-Binding Lectin Levels for 51

Cardiovascular Risk of Hemodialysis Patients

Journal of Translational Medicine, 2016

Chapter 5 Intradialytic Complement Activation Precedes the Development of 71

Cardiovascular Events in Hemodialysis Patients

Frontiers in Immunology, 2018

Chapter 6 Distinct Pathways Mediate Local and Systemic Complement Activation 91

in Peritoneal Dialysis

In preparation

Chapter 7 Distinct In-vitro Complement Activation by Various Intravenous 107

Iron Preparations

American Journal of Nephrology, 2017

Chapter 8 Administration of Intravenous Iron Preparations Induces 125

Complement Activation In-vivo

In submission

Chapter 9 Age and Sex-associated Changes of Complement Activity and 141

Complement Levels in a Healthy Caucasian population

Frontiers in Immunology, 2018

Chapter 10 Summary, Discussion and Future perspectives 169

Samenvatting, algemene discussie en toekomstperspectieven 177 Resumo, discussão e perspectivas futuras 185

List of publications 193

Acknowledgements 195

(7)

Referenties

GERELATEERDE DOCUMENTEN

To investigate the mechanism of increased cardiovascular risk in HD, we measured complement activation, pro-inflammatory cytokines and pro-thrombotic factors during one HD session

Since plasma sC5b-9 levels in PD patients were significantly higher than levels in ND-CKD patients and healthy controls, we believe that PD itself induces systemic

Furthermore, in the ex-vivo assay, ferric carboxymaltose and iron sucrose only caused significant complement activation in the blood of HD patients.. No in-vitro or ex-vivo

Furthermore, plasma levels of PTX3 were determined in 32 hemodialysis patients prior to and one hour after completing iron infusion during two consecutive sessions (B), one

There were no significant differences in CP activity or CP components between females and males, nevertheless females had significantly lower levels of the terminal components.. The

Yaseen S, Demopulos G, Dudler T, Yabuki M, Wood CL, Cummings WJ, Tjoelker LW, Fujita T, Sacks S, Garred P, Andrew P, Sim RB, Lachmann PJ, Wallis R, Lynch N, Schwaeble WJ:

One of the proposed mechanisms of complement activation in PD patients is that PD therapy decreases the expression of complement regulators such as CD55 and CD59 on the

Hemodialysis patients might benefit from complement inhibition only during the hemodialysis session, whereas peritoneal dialysis patients might need continuous complement